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Stage I Seminoma of the Testis. Adjuvant Radiotherapy 
or Surveillance? 
E. P. A L L H O F F , S U S A N N E L IEDKE, W . DE RIESE, C. STIEF and B. SCHNEIDER 
Departments of Urology and Biometry, Hannover Medical School, Hannover, Germany 
S u m m a r y — L a t e l y the role of rad io therapy in stage I seminoma of the testis has been ques t ioned by 
some authors w h o repor ted on a "su rve i l l ance" s t ra tegy for these patients. Since 1 9 8 0 , 1 2 4 pat ients 
w i t h seminoma of the test is have been referred to th is ins t i tu t ion ; 97 of 116 pat ients analysed 
presented w i t h stage I disease and 10 of these had e levated levels of ßHCG. 
A to ta l o f 6 4 pat ients w e r e g iven rad io therapy after o rch iec tomy and 33 entered a survei l lance 
p ro toco l . A f te r a median f o l l o w - u p of 4 8 mon ths , 3 pat ients in the survei l lance group relapsed after 
5, 13 and 4 9 m o n t h s and 2 of the i rradiated pat ients d id so after 25 and 33 months. Elevat ion of 
ß H C G w a s not s ign i f icant because none of these pat ients s h o w e d progression. 
A l o w rate of progress ion and exce l lent surv ival are associated w i t h standard t reatment 
( o r c h i e c t o m y and rad io therapy) and g o o d results have been achieved w i t h chemotherapy in cases 
of relapse. A survei l lance po l i cy is not r e c o m m e n d e d in stage I seminoma because of its s lower 
g r o w t h c o m p a r e d w i t h n o n - s e m i n o m a t o u s germ cel l t u m o u r s ( N S G C T ) , the absence of a specif ic 
t u m o u r marker, the 10% risk of o c c u l t metastases and the 3 - f o l d higher progression rate compared 
w i t h i r radiated pat ients. W e suggest the use of a reduced dosage and radiat ion f ie ld. 
Testicular seminoma has proved to be extremely 
responsive to therapy. After standard therapy— 
infradiaphragmatic lymph node irradiation—ex-
cellent cure rates have been reported, with survival 
rates of 85 to 90% in stage I tumours (Thomas et 
al., 1982; Peckham 1988; Fossa et al., 1989). In 
view of the low rate of occult metastases (in 
approximately 10% of cases) (Maier et al.9 1968) 
and the morbidity of radiation therapy (impaired 
spermatogenesis, peptic ulceration, bowel compli-
cations and second malignancies) (Hay et at., 1984; 
Hamilton et al., 1987; Coia and Hanks, 1988), it 
has been suggested that radiotherapy should be 
omitted. 
To find out if it is possible to reduce therapy 
without compromising patients' safety, we evalu-
ated the follow-up of patients with seminoma stage 
I who were treated either with adjuvant radiother-
apy or surveillance after orchiectomy between 1980 
and 1988 at Hannover Medical School. 
Accepted for publication 26 November 1990 
Patients and Methods 
Since 1980, 124 patients with seminoma of the 
testis have been referred to this institution. Eight 
patients were lost to follow-up; 7 of these had stage 
I tumours—6 in the radiotherapy group and 1 in 
the surveillance group. Of the remaining 116 
patients, 97 (83.6%) presented with stage I disease 
and thus could be analysed; 10 of these (10.5%) had 
elevated levels of ßHCG. Sixty-four patients were 
given radiotherapy after orchiectomy and 33 were 
assigned to a surveillance protocol. The decision on 
treatment was made by the patient himself after 
being fully informed of the advantages and disad-
vantages of both strategies. The median ages of 
32.5 years (range 18-67) in one group and 33 years 
(range 21-48) in the other group were comparable. 
Stage I seminoma was defined by (1) verification 
of a histologically pure seminoma, (2) ßHCG in the 
normal range or decreasing after orchiectomy 
(patients with elevated levels of alpha-fetoprotein 
(AFP) were treated as having non-seminomas) and 
(3) ultrasonography of the abdomen, C T of abdo-
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men and chest and conventional chest X-ray 
without evidence of tumour spread. 
Patients in the surveillance group were followed 
up closely with monthly examinations (AFP and 
ßHCG, chest X-ray and either C T scan or sono-
graphy) in the first year, 2-monthly in the second 
year and every 3 months in the third to fifth years. 
Irradiated patients were followed-up every 3 
months for the first 2 years and every 6 months for 
the third and fourth years, with annual visits 
thereafter. 
Results 
In all, 97 patients were followed up for a median of 
48 months (range 4-110) and 5 patients (5.2%) 
relapsed; 3 (9.1%) of the 33 patients in the 
surveillance group showed progression after 5, 13 
and 49 months and 2 of the irradiated patients 
(3.1%) did so after 25 and 33 months (Table 1). 
Details of relapse and treatment are summarised in 
Table 2. Of the 2 relapsing patients in the irradiated 
group, 1 developed isolated lung metastases and 
was treated with 4 cycles of chemotherapy (cisplatin 
vinblastine, bleomycin—PVB) and resection of 
Table 1 Surveillance versus Adjuvant Radiotherapy 
Surveillance Radiotherapy 
NED 30 
No. = 33 
/ 











NED = No evidence of disease. 
Table 2 Details of Relapse 
residual tumour. He has been disease-free for 65 
months. The other patient, who had a prior 
herniorrhaphy, showed progression in the irradi-
ated area, retroperitoneal and inguinal. He received 
2 cycles of PVB and secondary retroperitoneal 
lymph node dissection (RPLND) and has been 
disease-free for 46 months. All of the 3 relapsing 
patients in the surveillance group showed retroper-
itoneal progression and were cured by different 
types of therapy; carboplatin and secondary 
R P L N D and radiation or chemotherapy alone. No 
patient has died from his disease or from compli-
cations of treatment. 
Ten of the 97 patients (10.5%) had elevated levels 
of ßHCG prior to orchiectomy; 6 of them received 
adjuvant radiation therapy and 4 were entered into 
the surveillance protocol; none relapsed. 
Histopathologically we found 95 cases of classical 
seminoma, 1 anaplastic and 1 spermatocyte semi-
noma. 
Relapse occurred in 3% of patients with p T l 
tumours, 7% with pT2 and 17% with pT3 lesions 
(Table 3). To ascertain if there was a rise in relapse 
probability with increasing pT stage the trend test 
(Armitage, 1955) was applied (using the StatXact 
package (Mehta et al., 1988; Gajjar et al.9 1989). 
The exact one-sided P value for the observed trend 
was 0.08, so that the correlation was significant on 
the level of 10% but not 5%. 
Delay in presentation was assessed in 67/97 
patients, with 3 of these relapsing. The latter 
subgroup showed a preference for longer intervals 
(median 26 weeks) compared to the patients with 
no evidence of disease (NED) (median 3 weeks). 
The difference was statistically significant (log rank 
test, one-sided P value = 0.0387) (Kalbfleisch and 
Prentice, 1980). 
Four patients (4.1%) developed a secondary 
malignancy after 14, 16, 72 and 84 months: in 1 a 
No. of Time to relapse Status 
patients Radiotherapy (months) Site of relapse Treatment (months) 
1 Yes 33 Retroperitoneal/inguinal PVB + RPLND NED 46 
2 Yes 25 Pulmonary PVB + L-Op NED 65 
3 No 49 Retroperitoneal CP + RPLND NED 33 
4 No 5 Retroperitoneal RPLND+ RT NED 43 
5 No 13 Retroperitoneal/cervical Cisplatin NED 28 
PVB = Cisplatin, vinblastine, bleomycin. 
CP = Carboplatin. 
RPLND = Retroperitoneal lymph node dissection. 
L-Op = Resection of residual pulmonary tumour. 
RT = Radiotherapy. 
NED = No evidence of disease. 
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Table 3 pT Stage 
pT No. of patients (%) Relapses (%) 
1 64 2(3) 
2 27 2(7) 
3 6 1(17) 
seminoma and in 3 a non-seminomatous germ cell 
tumour of the contralateral testis. 
Discussion 
Many patients with seminoma of the testis have 
stage I disease at presentation, with percentages 
ranging between 69 and 84% (Caiman et al9 1979; 
Thomas et al9 1982; Krag-Jacobsen et al9 1984; 
Babaian and Zagars, 1988; Ellerbrock et al9 1988). 
In the present study, 83.6% presented with stage I 
disease, which would seem to indicate a low 
metastatic potential. The historical data of Maier 
et al. (1968) showed a 10% incidence of occult 
metastases in patients presenting with stage I 
seminoma, but the methods of staging at that time 
were unsatisfactory and the more precise imaging 
systems used today may mean that the rate of occult 
metastases is even lower. 
Excellent survival and low relapse rates have 
been reported in patients with seminoma of the 
testis stage I after orchiectomy and adjuvant 
radiotherapy (Table 4). Furthermore, there is 
effective salvage treatment for patients who relapse 
(Thomas etal., 1982; Loehrer etal, 1987). 
Table 4 Relapse Rates after Orchiectomy and Adjuvant 
Radiotherapy 
No. of No. of 
patients relapses Rate (%) 
Ball etal. {mi) 232 4 3.0 
Fossa er al. (1989) 365 13 3.5 
Hamilton et al. (1986) 232 5 2.0 
Thomas (1985) 150 2 1.0 
Zagars (1988) 163 7 4.2 
Table 5 Relapse Rates after Surveillance 
Successful results of a surveillance policy for 
stage I non-seminomatous germ cell tumours of the 
testis were reported by Peckham et al. (1982) and 
this raised the possibility of adopting a similar 
approach to stage I seminomas to avoid unnecessary 
additional therapy. Some initial results of the "wait 
and see" policy in testicular seminoma stage I 
revealed relapse rates of 3.7 to 13.4%, but follow-
up was relatively short (Table 5). 
Our relapse rate of 3.1% after adjuvant radiother-
apy is similar to that of other series (Table 4). 
Patients in the surveillance group showed progres-
sion in 9.1%, thus recording a relapse rate 3 times 
higher than that of irradiated patients. This includes 
1 patient with progression after 49 months and 
underlines the possibility of late recurrence in this 
group, as already described by other authors. 
Ellerbrock et al. (1988) reported a 30% relapse rate 
after 3 years, Caiman et al. (1979) reported 
recurrence after 6 years, and Warhol et al. (1983) 
after 17 years. 
Elevation of serum ßHCG is described in 10 to 
21% of seminoma patients (Mann and Siddle, 
1988), whereas morphological correlation (syncytio-
trophoblastic cells) could be established in only 4 to 
14.5% (Butcher et al.9 1985). Javadpour (1986) 
suggested a worse prognosis for patients with 
jSHCG-positive seminoma, but the results in our 
study (no relapse in 10 patients with elevated levels 
of ßHCG) corroborate the experience of other 
authors (Peckham et al., 1987; Babaian and Zagars, 
1988; Wilkinson et al, 1988). Thus we would not 
recommend a change from the usual policy for 
these patients. 
The side effects of adjuvant radiotherapy are 
relatively infrequent and usually affect the gastroin-
testinal tract (Peckham, 1988; Fossa et al.9 1989). 
Coia and Hanks (1988) reported about 4% of 
patients with severe complications requiring hos-
pitalisation in a series of 883 patients who received 
radiotherapy for seminoma or Hodgkin's disease. 
With dosages below 35 Gy, Prosnitz (1988) ob-
served only 1% of patients with major complica-
tions. The risk of infertility presents a special 
problem (Thomas et al.9 1977). Even with careful 
No. of Follow-up (months) Time (months) 
patients Median (range) Relapse Rate (%) Median (range) 
Horwich and Peckham (1988) 90 18(4-40) 10 11.0 11(7-24) 
Peckham et al. (1987) 52 23(12-41) 7 13.4 11 (6-23) 
Thomas et al. (1989) 81 19(3-43) 3 3.7 5 (3-18) 
Presentseries 33 48(4^110) 3 9.1 13(5-51) 
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scrotal shielding, either oligozoospermia or azoos-
permia persists in approximately 50% of irradiated 
men. However, it should be remembered that 22 to 
53% (Jewett and Jarvi, 1986) of all men after 
unilateral orchiectomy and before further therapy 
exhibit azoospermia and 25% of all patients with 
testicular tumours remain subfertile, regardless of 
therapy. On the other hand, the recovery of 
spermatogenesis after radiation therapy is possible. 
The problem of second malignancies after radio-
therapy has not yet been solved. Evaluation of the 
South Thames Cancer Registry for the period 1961 
to 1980 by Coleman et al. (1987) did not reveal an 
excessive incidence of second cancers among men 
with testicular cancer, apart from contralateral 
testicular neoplasms. For the latter the risk rose 
from 2.9 to 14.3 over the 2 decades, with relatively 
few men being treated by chemotherapy alone in 
either time period. Kaldor et al. (1987) reported a 
2-fold higher chance of developing second malig-
nancies in testicular cancer, but the study did not 
allow any differentiation with respect to the 
therapeutic approach previously selected. Hamil-
ton et al. (1986) suggested that there was no 
increased risk compared with the normal popula-
tion, but Hay et at. (1984) found a 9% incidence of 
second, non-testicular malignancies in patients 
irradiated between 1950 and 1969. Fossa et al. 
(1989) observed a 2-fold higher chance of develop-
ing second malignancies compared with the general 
population, though in this series tumours of the 
contralateral testis were included. 
A relapse rate of 9 to 13% in a surveillance policy 
seems to be acceptable, even in comparison with 
20 to 30% in N S G C T stage I. However, the time to 
relapse is usually longer than in N S G C T and it 
must be remembered that the follow-up in previous 
studies was relatively short. Furthermore, relapse 
is confined in most cases to the retroperitoneum, 
which is a more difficult area to assess by imaging 
techniques. Though all relapses have been salvaged, 
surveillance in seminoma patients might be consid-
ered more complicated and costly because a longer 
period of intensive follow-up is required. In 
addition, a satisfactory serum tumour marker has 
yet to be discovered. Placental alkaline phosphatase 
(PLAP) has been thought to be of value (Horwich 
et al., 1985), but observations of elevated levels of 
PLAP in 55 to 90% of seminoma patients with 
active disease (Horwich et al., 1985) would indicate 
a sensitivity lower than that required for reliable 
follow-up. 
The difference between 3.1% and 9.1% in 
irradiated and surveillance patients does not attain 
statistical significance, but in calculating the low 
number of overall relapses, about 20 000 probands 
are necessary to detect the proposed difference as 
significant with a power of 95% (Sachs, 1982). In 
spite of this, the 3-fold higher relapse rate must be 
emphasised, and so in our opinion radiotherapy 
remains an important and safe method of treatment 
for patients with seminoma stage I. 
A more vexing question is whether dosage and 
radiation field can be optimised. Total dosage 
should not exceed 30 Gy (Hanks et al., 1981) and 
satisfactory results have been obtained even with 
25 Gy (Thomas, 1985). Fossa et al. (1989) require 
that the inguinal region be excluded even in patients 
with a past history of inguinal or scrotal surgery. 
Radiation of the ipsilateral iliac region may also be 
questioned, since iliac tumour growth is rare, in 
patients with testicular cancer (Fossa et al., 1989). 
Considering these restrictions, immediate and long-
term morbidity can probably be reduced even 
further. 
Another option seems to be the use of carbopla-
tin : it has been established that seminoma, as well 
as being more radiosensitive than non-seminoma, 
is also more chemosensitive. This has been reflected 
by the observation that approximately 70% of 
patients can become disease-free with cisplatin 
alone (Oliver, 1987), compared with 10% of patients 
with N S G C T (Higby et al., 1974). Two courses of 
adjuvant treatment provide a realistic alternative 
to radiotherapy and may well be less toxic (Peckham 
et al, 1985; Oliver, 1987). It is probable that a 
prospective study comparing radiotherapy and 
carboplatin may be indicated in stage I seminoma. 
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